Novartis study positive for new acromegaly therapy
Home page > News

Novartis study positive for new acromegaly therapy

www.reuters.com   | 07.05.2012.

ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday study data showed a new therapy for people suffering from acromegaly, a rare disorder characterized by enlargement of the feet, hands and internal organs, was more effective than the treatment now commonly prescribed.
Novartis study positive for new acromegaly therapy

"Results of the largest Phase III study of acromegaly patients show the novel therapy pasireotide long-acting release, was significantly more effective at inducing full biochemical control compared to the current standard medical therapy," the company said in a statement.

(Reporting by Catherine Bosley)


Comments (0) Add Your comment Add news < Previous news Next news >






  Add your news >>>